(Boursier.com) — Surgical Amplitude publishes its activity accounts for the 1st quarter of 2022-23, marked by a consolidated turnover of 19.4 ME, +11.3%. Revenue before application of IFRS 5 (Extremities activities included) was €23.9 million, +14.1% at constant rates with continued growth in extremities activities (Novastep) of +28.8% at constant rates .
Olivier Jallabert, Chief Executive Officer of Amplitude Surgical, said: “During the first quarter of the 2022-23 financial year, Amplitude Surgical posted an increase in Group revenue before application of IFRS 5 of 14.1 % benefiting from almost normal availability of operating rooms, which was not the case during the first quarter of the previous financial year Knees and hips activities posted an increase of 11.3% at constant exchange rates Novastep continued its development to represent approximately 18.8% of Group revenue before application of IFRS 5, with growth of nearly 29% during the period”.
Next press release: H1 2022-23 revenue, Thursday February 23, 2023, after market close.
©2022 Boursier.com